Maintenance work on the ZORA database servers is scheduled for Thursday 25th July 2019 from 19:00-20:00. During this period ZORA and JDB will not be available. Thank you for your understanding.
von Gumberz, J; Mahmoudi, M; Young, K; Schippling, S; Martin, R; Heesen, C; Siemonsen, S; Stellmann, J P (2016). Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting. PeerJ, 4:e2442.
Lutterotti, A; Yousef, S; Sputtek, A; Stürner, K H; Stellmann, J P; Breiden, P; Reinhardt, S; Schulze, C; Bester, M; Heesen, Ch; Schippling, S; Miller, S D; Sospedra, M; Martin, R (2013). Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis. Science Translational Medicine, 5(188):188ra75.
Stellmann, J P; Neuhaus, A; Herich, L; Schippling, S; Roeckel, M; Daumer, M; Martin, R; Heesen, C (2012). Placebo cohorts in phase-3 MS treatment trials - predictors for on-trial disease activity 1990-2010 based on a meta-analysis and individual case data. PLoS ONE, 7(11):e50347.